Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma (Q39424270)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma |
scientific article |
Statements
1 reference
Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma (English)
1 reference
Marco Volante
1 reference
Mauro Papotti
1 reference
Alfredo Berruti
1 reference
Anna Ferrero
1 reference
Paola Sperone
1 reference
Arianna Ardito
1 reference
Adriano Massimiliano Priola
1 reference
Silvia De Francia
1 reference
Fulvia Daffara
1 reference
Sophie Leboulleux
1 reference
Paola Perotti
1 reference
Eric Baudin
1 reference
21 December 2011
1 reference
1 reference
166
1 reference
3
1 reference
451-458
1 reference
Identifiers
1 reference
1 reference